FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 15:46:54 2024-05-17 EDT | ||
| 4.09 EUR | +3.02% |
|
| Current month | -63.58% | ||
| 1 month | -68.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 4.09 | +3.02% |
| 24-05-16 | 3.97 | +3.93% |
| 24-05-15 | 3.82 | -11.16% |
| 24-05-14 | 4.3 | -4.87% |
| 24-05-13 | 4.52 | +4.15% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 03:46 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEG |
| ISIN | DE000HD2VEG8 |
| Date issued | 2024-02-21 |
| Strike | 393.4 $ |
| Maturity | Unlimited |
| Parity | 19.12 : 1 |
| Emission price | 10.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.73 € |
|---|---|
| Lowest since issue | 3.82 € |
| Spread | 0.01 € |
| Spread % | 0.24% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat